Poly Medicure Expands European Footprint Through PendraCare Acquisition
About Poly Medicure
Poly Medicure is an Indian medical devices manufacturer known for its high-quality disposable medical products. The company specializes in infusion therapy, IV cannula, blood bag systems, and other hospital consumables, with a focus on innovation and global distribution.
Deal Highlights
- Acquired 90% stake in Europe-based PendraCare Group for EUR 11M upfront plus EUR 3.2M in inter-group loans.
- PendraCare CY24 performance: Revenue EUR 9.9M | EBITDA EUR 1.4M | PBT EUR 0.8M | Gross Margin 74%
- Valuation metrics: 1.8x EV/Revenue | 13x EV/EBITDA
- Strategic expansion in cardiology sector with potential synergies in manufacturing, R&D, and distribution.
- Expected synergy contribution: EUR 3M–4M incremental EBITDA within 3–4 years.
- Long-term revenue target: EUR 25M by 2030.
Impact Analysis
🟢 Positive – The acquisition strengthens Poly Medicure’s global presence, accelerates growth potential, and unlocks operational synergies in the cardiology segment.
Investor Takeaway
This move positions Poly Medicure to benefit from European market expansion and long-term revenue growth. Investors may view the acquisition positively due to enhanced operational synergies and potential EBITDA uplift.
For traders looking to navigate this phase, you can utilize the tips provided below:
👉 Nifty Tip |
BankNifty Tip
📌 Access insightful updates and research at Indian-Share-Tips.com, which is a SEBI Registered Advisory Services.
SEBI Disclaimer: The information provided in this post is for informational purposes only and should not be construed as investment advice. Readers must perform their own due diligence and consult a registered investment advisor before making any investment decisions. The views expressed are general in nature and may not suit individual investment objectives or financial situations.
